CTi Biopharma Corp (NASDAQ:CTIC)

1.93
Delayed Data
As of Jul 28
 +0.07 / +3.76%
Today’s Change
1.65
Today|||52-Week Range
2.94
-18.22%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$335.2M

Company Description

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Contact Information

CTI BioPharma Corp.
3101 Western Avenue
Seattle Washington 98121
P:(206) 282-7100
Investor Relations:
(206) 272-4343

Employees

Shareholders

Individual stakeholders3.43%
Other institutional17.92%
Mutual fund holders14.93%

Top Executives

James A. BiancoPresident, Chief Executive Officer & Director
Lou A. BiancoExecutive Vice President-Finance & Administration
Jack W. SingerDirector & Executive VP-Global Medical Affairs
Matthew J. PlunkettExecutive Vice President-Corporate Development
Bruce J. SeeleyChief Commercial Officer & Executive Vice Presiden

To view my watchlist

Not a member yet?

Sign up now for a free account